Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research and pharmaceuticals: EU ‘pharming’ solutions to major diseases

22.07.2004


A team of European researchers plans to perfect techniques for producing antibodies and vaccines, obtained from plants, to prevent and treat major human diseases, such as AIDS, rabies and TB. The idea is to use genetically modified (GM) crops eventually to produce plant-based pharmaceuticals. Pharma-Planta is a consortium of eleven European countries and South Africa which, thanks to €12 million in EU funding, plans to produce vaccines and other treatments for major diseases, such as HIV/AIDS, rabies and tuberculosis. The project, led by the Fraunhofer Institute for molecular biology and ecology in Aachen (Germany), with scientific co-ordination by St George’s Hospital Medical School in London (UK), hopes to start clinical trials by the end of the funding period in 2009.

“The development of new drugs derived from plants, made possible thanks to recent advances in plant genetics, can benefit from cross-disciplinary collaboration at European level” commented Research Commissioner Philippe Busquin about this EU project. “The consortium of 39 research teams from across Europe and South Africa will combine expertise across disciplines, such as immunology and plant sciences, to offer real promise in this complex high-technology area.”

“Pharming”



Plant-based pharmaceutical production, or ‘pharming’, offers several advantages over traditional approaches. The current methods used to generate these types of treatments involve culturing cells or microorganisms, such as bacteria which are labour intensive, expensive and often only produce relatively small amounts of pharmaceuticals. But plants are inexpensive to grow and if “engineered” to contain a gene for a pharmaceutical product, they could produce large quantities of drugs or vaccines at low cost.

First concrete applications

The first product that might come out of the EU integrated project, possibly grown in maize, is likely to be an antibody that neutralises the AIDS virus. This could be incorporated for example, in a simple-to-apply microbicidal cream and used for blocking HIV transmission. Next would probably be a monoclonal antibody against rabies – still a major killer in the developing world and responsible for up to 70,000 deaths a year – which could be used after contracting the virus.

Checks and balances

The production of pharmaceuticals in GM plants would be subject to control by multiple regulatory agencies, including those governing the use of genetically modified organisms and those governing the production of drugs. Part of Pharma-Planta’s remit will also be to identify secure methods and places for production.

Although the consortium has yet to decide which plants to use, likely candidates include maize, tobacco and tomatoes. Plants possessing the desired proteins for producing so-called ‘immunotherapeutic bio-molecules’ – which can be found in high enough quantities in the seeds and harvested easily – will be given preference.

Fabio Fabbi | European Union
Further information:
http://www.europa.eu.int
http://www.pharma-planta.org

More articles from Life Sciences:

nachricht Kidney tumor: Genetic trigger discovered
19.06.2018 | Julius-Maximilians-Universität Würzburg

nachricht New type of photosynthesis discovered
18.06.2018 | Imperial College London

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

Im Focus: Photoexcited graphene puzzle solved

A boost for graphene-based light detectors

Light detection and control lies at the heart of many modern device applications, such as smartphone cameras. Using graphene as a light-sensitive material for...

Im Focus: Water is not the same as water

Water molecules exist in two different forms with almost identical physical properties. For the first time, researchers have succeeded in separating the two forms to show that they can exhibit different chemical reactivities. These results were reported by researchers from the University of Basel and their colleagues in Hamburg in the scientific journal Nature Communications.

From a chemical perspective, water is a molecule in which a single oxygen atom is linked to two hydrogen atoms. It is less well known that water exists in two...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Novel method for investigating pore geometry in rocks

18.06.2018 | Earth Sciences

Diamond watch components

18.06.2018 | Process Engineering

New type of photosynthesis discovered

18.06.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>